207. ASCO 2026 - Agents of the Future - Part 2

This week, Josh and Michael's ASCO 2026 coverage looks at "Agents of the Future", trials of intrigue, promise and potential beyond its status. This episode also sheds light on more orphan status cancers like head and neck cancer, basket cohort studies, resistant EGFR lung cancer, metastatic colorectal cancer and hepatocellular carcinoma.

One more episode left of this arc - The Plenary! Stay tuned.

Studies Discussed in this Episode

OrigAMI-4

WU-KONG28

A Phase 1/2 Study of JK06, a 5T4-Targeted Antibody Drug Conjugate (ADC), In Patients with Unresectable Locally Advanced or Metastatic Cancer

ESANOA

ROSETTA Lung-02

Ivonescimab + FOLFOX

HERIZON-CRC01

CIRCULATE

EMERALD-3